https://www.bloomberg.com/news/articles/2021-10-04/guardant-health-is-said-to-decide-against-neogenomics-takeover
Related Posts
Travelzoo Launches Metaverse Division
Travelzoo (NASDAQ: TZOO), a New York City-based internet company that provides travel offers and experiences for its membership base, is launching a Metaverse division in April.
Otis To Buyout Interest In Zardoya Otis
Otis Worldwide Corp (NYSE:OTIS) announced a tender off for all of the shares it does not currently own in Zardoya Otis, S.A. for…
Benchmark Initiates Coverage On Cactus with Buy Rating, Announces Price Target of $70
Benchmark analyst Kurt Hallead initiates coverage on Cactus (NYSE:WHD) with a Buy rating and announces Price Target of $70.